Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 5.91Yasons Chemex Care Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates strong solvency and notable growth in revenue and operating profit. Profitability metrics, particularly gross profit and operating margins, are also robust. However, liquidity is weak, and certain efficiency and financial metrics indicate areas needing attention. While the company shows promise in revenue and profit growth, inconsistent earnings per share and net income growth, coupled with low coverage ratios and returns on equity and assets, present challenges. Overall, the company's strengths in solvency, revenue, and operating profit growth are somewhat offset by liquidity issues and inconsistent profitability and efficiency metrics. Future performance will likely depend on addressing these inconsistencies and leveraging its growth potential effectively.
Health Score : 5.91Yasons Chemex Care Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates strong solvency and notable growth in revenue and operating profit. Profitability metrics, particularly gross profit and operating margins, are also robust. However, liquidity is weak, and certain efficiency and financial metrics indicate areas needing attention. While the company shows promise in revenue and profit growth, inconsistent earnings per share and net income growth, coupled with low coverage ratios and returns on equity and assets, present challenges. Overall, the company's strengths in solvency, revenue, and operating profit growth are somewhat offset by liquidity issues and inconsistent profitability and efficiency metrics. Future performance will likely depend on addressing these inconsistencies and leveraging its growth potential effectively.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
19.69
Industry Median
37.37
Small Cap Median
35.04
P/E RATIO
19.69
P/B RATIO
0.45
Industry Median
2.51
Small Cap Median
2.21
P/S RATIO
0.19
Industry Median
2.34
Small Cap Median
1.88
Others
PEG RATIO
0.00
EV/EBITDA RATIO
5.44
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹9.65 as on Aug 12, 2026.
Growth Score : 6.00The company's growth ratio indicates very strong performance in revenue and operating profit, but lower performance in EPS and net income growth. The strong growth in revenue and operating profit could be promising, but the company needs to focus on translating this growth into improved earnings per share and net income.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 0 | 88.31 | 10.53 | 26.51 | |
| Operating Profit Growth Rate | 0 | 430.61 | -51.15 | -146.46 | |
| Earnings Per Share (EPS) Growth | -58.35 | -73.14 | 29.23 | -41.67 | |
| Asset Growth Rate | 97.86 | 8.68 | 14.5 | ||
| Net Income Growth Rate | 0 | -63.56 | 29.6 | -41.98 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Saroja Pharma Industries India Ltd | 7.47 | 13.67 | Neutral | 3.81 | 4.02 | 1.62 |
| 2 | Sanginita Chemicals Ltd | 7.17 | 62.58 | Undervalued | -6.00 | -3.74 | -10.00 |
| 3 | Yasons Chemex Care Ltd | 5.91 | 19.08 | Neutral | -0.59 | 0.49 | 0.94 |
| 4 | Vadivarhe Speciality Chemicals Ltd | 4.07 | -3.15 | Highly Undervalued | -6.42 | -7.25 | -9.27 |
| 5 | Omkar Speciality Chemicals Ltd | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Yasons Chemex Care Ltd (YCCL) is an Indian manufacturer and exporter specializing in dyes, pigments, and dyes intermediates. Catering to textiles, paper, leather, and food industries, the company focuses on delivering high-quality specialty chemicals and custom solutions, establishing a notable presence in its niche market.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Yasons Chemex Care Ltd's P/E ratio (TTM) is 19.69, compared to the industry median of 37.37 and large cap median of 35.04.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Yasons Chemex Care Ltd's P/B ratio is 0.45, compared to the industry median of 2.51 and large cap median of 2.21.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Yasons Chemex Care Ltd's P/S ratio is 0.19, compared to the industry median of 2.34 and large cap median of 1.88.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Yasons Chemex Care Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Yasons Chemex Care Ltd's EV/EBITDA ratio is 5.44.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Yasons Chemex Care Ltd's ROE is 2.26%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Yasons Chemex Care Ltd's ROA is -0.87%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Yasons Chemex Care Ltd's ROCE is 5.26%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Yasons Chemex Care Ltd's operating margin is -0.61%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Yasons Chemex Care Ltd's net margin is 0.97%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Yasons Chemex Care Ltd's current ratio is 2.47.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Yasons Chemex Care Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Yasons Chemex Care Ltd's interest coverage ratio is 2.20.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Yasons Chemex Care Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Yasons Chemex Care Ltd's EPS is -41.67.
(Source line: "Ratios as of 12 Aug 2026, based on last traded price of ₹9.65. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Yasons Chemex Care Ltd was incorporated on January 16, 2013, as a Private Limited Company. It transitioned to a Public Limited Company in 2018. The company further achieved a significant milestone by getting listed on the BSE SME platform through an IPO in 2023, solidifying its position as a manufacturer and exporter of specialty chemicals, dyes, and intermediates.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Dyes & Pigments | 100% | Operating Profit |
Mr. Kamleshkumar Shantilal Patel - Chairman & Managing Director. As one of the founders, he brings extensive experience in the chemical sector, guiding the company's strategic direction and growth.
No major subsidiaries reported.
The primary recent corporate action was its Initial Public Offering (IPO) on the BSE SME platform in 2023. No major bonus issues, rights issues, or significant M&A activities are on record.
References
The Yasons Chemex Care Ltd share price today is ₹9.65 on NSE (YCCL), as of 12 Aug 2026.
As of 12 Aug 2026, Yasons Chemex Care Ltd share price is ₹9.65, with previous close ₹N/A. Today's range is ₹N/A to ₹N/A. The 52-week range is ₹N/A to ₹N/A.
As of today, Yasons Chemex Care Ltd's market cap is ₹18.62 crore (Small Cap).
Yasons Chemex Care Ltd's current P/E ratio is 19.69, compared to the CHEMICALS & PETROCHEMICALS sector average of 31.50.
Yasons Chemex Care Ltd's current P/B ratio is 0.45.
Yasons Chemex Care Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Yasons Chemex Care Ltd's EPS (TTM) is ₹-41.67.
Yasons Chemex Care Ltd (YCCL) is an Indian manufacturer and exporter specializing in dyes, pigments, and dyes intermediates. Catering to textiles, paper, leather, and food industries, the company focuses on delivering high-quality specialty chemicals and custom solutions, establishing a notable presence in its niche market.
Yasons Chemex Care Ltd is promoted by Kamleshkumar Shantilal Patel, Shaileshbhai Shantilal Patel, Rajeshkumar Shantilal Patel and their group entities (e.g., Sanskar Chemex Private Limited), holding 51.47% as of 12 Aug 2026.
Yasons Chemex Care Ltd is listed on NSE (YCCL) and BSE ({bse}). Its next quarterly results are expected on Q1 FY25 (July/August 2024).
Cash Earnings Per Share (Cash EPS)